KALOUN EL BACHIR,BEDJEGUELAL KARIM,RABOT REMI,KRUCZYNSKI ANNA,SCHMITT PHILIPPE,PEREZ MICHEL,RAHIER NICOLAS
申请号：
IN7013/DELNP/2013
公开号：
IN2013DN07013A
申请日:
2013.08.06
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same a tautomer of same or a stereoisomer or mixture of stereoisomers of same in any proportions such as a mixture of enantiomers notably a racemic mixture as well as to the use of same as a drug notably intended for the treatment of cancer inflammation and neurodegenerative diseases such as Alzheimer s disease to the use of same as a kinase inhibitor to the pharmaceutical compositions comprising same and to methods for the preparation of same.
